Using an accelerated course of radiation therapy “does not increase complications” in patients who undergo breast reconstruction after a mastectomy, according to results from the phase III RT CHARM trial presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting. The study is the “first multi-institutional international study to show that a shorter course of post-mastectomy radiation, combined with breast reconstruction, is safe and effective,” according to ASTRO officials. Matthew M. Poppe, MD, FASTRO, the principal investigator of the trial and a professor of radiation oncology at the University of ...